GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 NGS Genetic DNA Test
Introduction
The GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 NGS Genetic DNA Test is a vital diagnostic tool designed to identify genetic mutations linked to severe neurological disorders in infants. This test employs Next Generation Sequencing (NGS) technology to provide comprehensive insights into the genetic factors contributing to early infantile epileptic encephalopathy. Understanding these genetic components is crucial for developing effective treatment strategies and improving patient outcomes.
What the Test Measures
This test specifically detects mutations in the GRIN2D gene, which are associated with early infantile epileptic encephalopathy type 46. By analyzing the DNA, we can identify genetic variations that may be responsible for the neurological symptoms observed in affected infants.
Who Should Consider This Test
Parents or guardians of infants exhibiting the following symptoms should consider the GRIN2D Gene test:
- Severe and recurrent seizures
- Developmental delays
- Abnormal muscle tone
- Other neurological deficits
Additionally, families with a history of neurological disorders may benefit from this test, as it can provide critical information for diagnosis and management.
Benefits of Taking the Test
- Early and accurate diagnosis of genetic causes of neurological disorders.
- Guidance for tailored treatment plans based on genetic findings.
- Informed family planning and risk assessment for future pregnancies.
- Access to genetic counseling resources for ongoing support.
Understanding Your Results
Results from the GRIN2D Gene test will be interpreted by our specialist neurologists and genetic counselors. They will provide insights into the genetic findings and their implications for the child’s health and management. It is important to discuss the results thoroughly to understand the next steps.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book the Test
To book the GRIN2D Gene Early Infantile Epileptic Encephalopathy Type 46 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling and any inquiries you may have.
Turnaround time for results is approximately 3 to 4 weeks. The sample type required can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a genetic counseling session is recommended to gather the clinical history of the patient and to create a pedigree chart of family members affected with the GRIN2D gene disorder.
